Congress of psychiatry

(LI-CBT) – background and evidence base of a new 
paradigm in mental health care
André Nienaber, Germany
002
  Cost and Outcome of Behavioural Activation 
versus Cognitive Behaviour Therapy for Depression 
(COBRA): results of a non-inferiority randomised 
controlled trial
David Richards, United Kingdom
003
  Time-use programs: manualized LI-CBT-Inter-
ventions delivered by occupational therapy
Werner Höhl, Germany
004
  Low intensity CBT – how to implement different 
models in practice
Pascal Wabnitz, Germany
S-110 Symposium
17:00 – 18:30
 | 
Hall New York 2
TOPIC 10:
 Gerontopsychiatry
Dealing with desire to die at the end-of-life: the 
German experience
Chairs: 
Reinhard Lindner, Germany 
Raymond Voltz, Germany
001
  Euthanasia, killing on request, and assisted 
suicide: historical opinions of German physicians 
(1800-2000)
Daniel Schäfer, Germany
002
  Psychotherapeutical approaches to deal with 
wishes to die at the end-of-life
Reinhard Lindner, Germany
003
  Palliative medicine and the wish for hastening 
death
Raymond Voltz, Germany
S-111 Symposium
17:00 – 18:30
 | 
Room M1
TOPIC 13:
 Brain imaging, neurophysiology, 
neuropsychology
Neurobiological causes of psychosis and ADHD: novel 
insight from genetic, neuroimaging, behavioral, and 
computational approaches
Chairs: 
Jakob Kaminski, Germany 
Yuliya Zaytseva, Czech Republic
001
  Neuroimaging contributions to neurodevelop-
mental disorders research: the case of ADHD
Felipe Picon, Brazil
002
  Instructional control of reinforcement learning 
in schizophrenia
Dorota Frydecka, Poland
Kamila Kotowicz, Jaroslaw Drapala
003
  Fronto-parietal connectivity in patients with 
schizophrenia
Jakob Kaminski, Germany
004
  Predictive modelling of cognitive dysfunction in 
schizophrenia from the resting state network brain 
connectivity
Yuliya Zaytseva, Czech Republic
S-112 Symposium
17:00 – 18:30
 | 
Room M8
TOPIC 25:
 Training and continuing education
Integrating psycho-oncology and primary care in 
the comprehensive management of cancer patients
›
 WPA Section: Psychiatry, Medicine & Primary Care
›
 WPA Section: Psycho-oncology and Palliative Care
Chairs: 
David Baron, USA 
Luigi Grassi, Italy
001
  Integrating primary care and psycho-oncology: 
improving quality of life for cancer patients
Michelle Riba, USA
002
  Training non-psychiatric physicians to appre-
ciate behavioral health and coping styles in cancer 
patients
Bulent Coskun, Turkey
003
  Challenges in effectively running an integrated 
psycho-oncology unit
Luigi Grassi, Italy

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
121
SCIENTIFIC
 PROGRAMME
S-113 Symposium
17:00 – 18:30
 | 
Room Weimar 3
TOPIC 24:
 Forensic psychiatry and assessment
Current forensic issues
›
 ZONE 15: Western & Central Asia
›
 ZONE 16: Southern Asia
Chair: 
Khalid Attaullah Mufti, Pakistan
001
  Forensic psychiatry services in Pakistan
Khalid Attaullah Mufti, Pakistan
002
  Truths about lie detectors
T. V. Asokan, India
003
  Highlights of psycho-legal issues in a prospec-
tive data of a tertiary care hospital in Pakistan
Fareed A. Minhas, Pakistan
004
  Challenges in implementing mental health 
legislation in Pakistan
Asad Tamizuddin Nizami, Pakistan
S-114 Symposium
17:00 – 18:30
 | 
Room Weimar 5
TOPIC 23:
 Health care research and models, health care 
policy
Migration of patients and doctors – effect on mental 
health systems
Chairs: 
Olga Kazakova, Belarus 
Anna-Karina Jakovljevic, Germany
001
  Psychiatrists' brain drain – is it a problem?
Mariana Pinto da Costa, Portugal
002
  The mental health in ecological migrants com-
pared with local residents and original residents in 
Ningxia province, China
Zhizhong Wang, People's Republic of China
003
  Migration, ethnicity and mental disorders – 
social epidemiological observations from the UK
Jayati Das-Munshi, United Kingdom
004
  Epidemiology of psychiatric disorders in  
countries with high level of migration
Tolga Binbay, Turkey
S-115 Symposium
17:00 – 18:30
 | 
Room Lindau 3
TOPIC 3:
 Psychotic disorders
Biological diagnostics of schizophrenia subsets
Chairs: 
Carsten Korth, Germany 
Hannelore Ehrenreich, Germany
001
  Disease biomarkers for schizophrenia – from 
laboratory to patient bedside
Sabine Bahn, United Kingdom
002
  All naturally occurring autoantibodies against 
the NMDA receptor subunit NR1 have pathogenic 
potential irrespective of epitope and immunoglobu-
lin class
Hannelore Ehrenreich, Germany
003
  Brain-imaging markers of treatment-resistant 
schizophrenia
Elias Mouchlianitis, United Kingdom
004
  Re-defining human sporadic mental illness by a 
blood test reverse translated from a transgenic rat 
model
Carsten Korth, Germany
S-116 Symposium
17:00 – 18:30
 | 
Room Lindau 6
TOPIC 16:
 Diagnostics and classification, 
psychopathology, RDoC
NIMH global research domain criteria (Global RDoC) 
intersectional symposium: improving treatment 
response and outcomes
›
 WPA Section: Psychiatry of Intellectual Disability
›
 WPA Section: Psychoneurobiology
Chairs: 
Kerim Munir, USA 
Stevan Weine, USA
001
  Informing dimensional aspects of stress and 
resilience and mental health problems following 
social adversities in LMICs
Stevan Weine, USA
002
  Informing understanding of boundaries and 
psychopharmacological management of neurodevel-
opmental disorders
Marco Bertelli, Italy
003
  Understanding the role of attentional bias and 
rumination as a measure of increased sensitivity to 
depression
Aliriza Arenliu, Republic of Kosovo
004
  Improving understanding of premorbid func-
tioning, negative symptoms and poor outcomes in 
schizophrenia
Armida Mucci, Italy

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
122
SCIENTIFIC
 PROGRAMME
S-117 Symposium
17:00 – 18:30
 | 
Room Dessau 3
TOPIC 44:
 Other topics
Mental health economics
›
 WPA Section: Mental Health Economics
Chairs: 
Massimo Moscarelli, Italy 
Susan Busch, USA
001
  Availability bias and provider treatment choice: 
evidence from treatment for adolescent depression
Susan Busch, USA
002
  Methodological development and standardiza-
tion of health economics in the youth population
Silvia Evers, The Netherlands
003
  US FDA key patient reported disease-related 
symptoms measurement and schizophrenia
Massimo Moscarelli, Italy
S-118 Symposium
17:00 – 18:30
 | 
Room R2
TOPIC 26:
 Ethics and philosophy
Ethical and clinical dilemmas in psychiatry
›
 WPA Section: Evidence Based Psychiatry
›
 WPA Section: Psychiatry, Law and Ethics
Chairs: 
Kuruvilla Thomas, India 
Athanassios Douzenis, Greece
001
  Personality disorders and violence
Kostas Fountoulakis, Greece
002
  Involuntary treatment in psychiatry
Kuruvilla Thomas, India
003
  Ethical dilemmas in the practice of forensic 
psychiatry
Christos Tsopellas, Greece
004
  Euthanasia in psychiatric patients
Georgios Tzeferakos, Greece
S-027 (d) 
Symposium (German)
17:00 – 18:30
 | 
Hall Helsinki 1
 
TOPIC 39:
 Social discrimination against people with 
mental illness
 
Rassistisch, extremistisch und religiös moti-
vierte Gewalt und ihre Folgen auf die psychische 
Gesundheit
›
 DGPPN Section: Interkulturelle Psychiatrie und  
Psychotherapie, Migration
Chairs: 
Meryam Schouler-Ocak, Germany 
Iris Tatjana Graef-Calliess, Germany
001
  Einführung in die Thematik und neurobiologi-
sche Zusammenhänge
Andreas Heinz, Germany
002
  Statistische Daten aus Deutschland und psychi-
sche Folgen
Ricarda Nater-Mewes, Germany
003
  Religiöse Gewalt, Identitätssuche und ihre 
Folgen
Seyran Ates, Germany
004
  Rassistische und politisch rechts motivierte 
Gewalt und ihre Folgen
Heike Kleffner, Germany
S-028 (d) 
Symposium (German)
17:00 – 18:30
 | 
Hall Berlin 2
 
TOPIC 4:
 Affective disorders
 
Somatische Therapiemöglichkeiten bei therapie-
resistenter Depression im klinischen Alltag
Chairs: 
Sarah Kayser, Germany 
Thomas E. Schläpfer, Germany
001
  Therapieresistente Depression – Definition, 
Krankheitsentwicklung und klinische Bedeutung
Thomas E. Schläpfer, Germany
002
  Pharmakologische Strategien zur Behandlung 
therapieresistenter Depressionen
Mazda Adli, Germany
003
  Elektrokonvulsionstherapie und Magnetkonvul-
sionstherapie in der klinischen Anwendung
Sarah Kayser, Germany
004
  Transkranielle Gehirnstimulationsverfahren 
(rTMS und tDCS) bei therapieresistenten Depressionen
Frank Padberg, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
123
SCIENTIFIC
 PROGRAMME
S-029 (d) 
Symposium (German)
17:00 – 18:30
 | 
Hall London 3
 
TOPIC 4:
 Affective disorders
 
Akut- und Langzeitstrategien bei der Behand-
lung bipolarer Depressionen 
›
 DGBS – Deutsche Gesellschaft für Bipolare  
Störungen e.V.
Chairs: 
Martin Schäfer, Germany 
Andreas Reif, Germany
001
  Pharmakotherapie der uni- und bipolaren  
Depression: Gibt es Unterschiede?
Ulrich Hegerl, Germany
Roland Mergl
002
  Psychotherapie der bipolaren Depression
Thomas Stamm, Germany
003
  Sozialpsychiatrische Aspekte in der  
Langzeittherapie bipolarer Patienten
Peter Brieger, Germany
004
  Länderübergreifende Versorgungsdaten bei 
bipolaren Depressionen
Hans-Jörg Assion, Germany
S-030 (d) 
Symposium (German)
17:00 – 18:30
 | 
Room  M2 / 
       
M3
TOPIC 15:
 Cross-disorder mechanisms and principles
 
Defizite der sozialen Interaktion bei Patienten 
mit psychischen Erkrankungen: störungsspezifische 
Charakteristika und Behandlungsansätze
Chairs: 
Dirk Wildgruber, Germany 
Ute Habel, Germany
001
  Soziale Wahrnehmung: störungsspezifische 
Defizite und Behandlungsansätze
Dirk Wildgruber, Germany
Heike Jacob, Carolin Brück, Benjamin Kreifelts
002
  Neuronale Korrelate sozialer Kognition:  
Geschlechts- und Störungsaspekte
Ute Habel, Germany
003
  Lachperzeption bei sozialer Angst: Störungsme-
chanismen und therapeutische Implikationen
Benjamin Kreifelts, Germany
004
  Soziale Wahrnehmungs- und Bewertungspro-
zesse bei der Borderline-Persönlichkeitsstörung
Stefanie Lis, Germany
Martin Bohus
S-031 (d) 
Symposium (German)
17:00 – 18:30
 | 
Room M6
TOPIC 29:
 Quality assurance in psychiatry
 
Notwendigkeit niedrigschwelliger Hilfen
Chairs: 
Karl-Heinz Möhrmann, Germany 
Karl H. Beine, Germany
001
  Hilf dir selbst, sonst tut es keiner
Karl H. Beine, Germany
002
  Kaffeegestütztes Krisenkontaktangebot Offene 
Tür statt Notfalleinsatz
Christiane Tilly, Germany
003
  Respekt vor der Autonomie eines psychisch 
kranken Menschen oder unterlassene Hilfeleistung
Hans-Jochim Meyer, Germany
S-032 (d) 
Symposium (German)
17:00 – 18:30
 | 
Room Weimar 1
TOPIC 23:
 Health care research and models, health care 
policy
 
Umfassende Daten zum Thema psychiatrische 
Versorgung in einer europäischen Metropole am 
Beispiel Wiens
Chairs: 
Robert Herz, Austria 
Ewald Lochner, Austria
001
  Internationale Vergleiche und Schlussfolgerungen
Robert Herz, Austria
002
  Wiener  Psychiatrie- / Psychotherapiedaten  – 
Gründe, Hintergründe, Methodik und Steuerungs-
modelle
Ewald Lochner, Austria
003
  Zu erwartende versus überraschende Daten – 
eine Auswahl
Friedrich Schmidl, Austria
WS-09 Workshop
17:00 – 18:30
 | 
Room  M4 / M5
TOPIC 44:
 Other topics
Implementing the DSM-5 cultural formulation inter-
view in clinical practice
Chairs: 
Roberto Lewis-Fernandez, USA 
Simon Groen, The Netherlands
Speaker: 
Sofie Bäärnhielm, Sweden

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
124
SCIENTIFIC
 PROGRAMME
OS-19 
Oral Presentation Session
17:00 – 18:30
 | 
Room R3
TOPIC 17:
 Psychotherapy
Psychotherapeutical interventions II
Chairs: 
César A. Alfonso, USA 
Ulrich Voderholzer, Germany
001
  Developing and testing of culturally adapted 
cognitive behaviour therapy for common mental 
disorders of Pashto speaking Pakistanis and Afghans
Muhammad Irfan, Pakistan
002
  The role of decentering techniques in cognitive 
behaviour therapy for depression
Rute Cajão, Portugal
Serrano Raquel, Teresa Carvalhão, Fernando Pocinho
003
  Group transdiagnostic cognitive behavior 
therapy in adolescents with headache and anxiety 
disorder
Pragya Sharma, India
Manju Mehta, Rajesh Sagar, Rachna Bhargava
004
  The use of third wave psychotherapies in the 
treatment of sexual health problems
Carla Ferreira, Portugal
Lígia Castanheira
005
  Computer-assisted cognitive remediation therapy 
increases hippocampal volume in schizophrenia
Tsubasa Morimoto, Japan
Yasuhiro Matsuda, Kiwamu Matsuoka, Fumihiko 
Yasuno, Emi Ikebuchi, Hiroyuki Kameda, Toshiaki Taoka, 
Toshiteru Miyasaka, Kazumichi Hashimoto, Yasunari 
Yamaguchi, Junya Ueda, Ryohei Takada, Shizuka 
Taguchi, Teppei Tanaka, Takeshi Nagahama, Kimihiko 
Kichikawa, Toshifumi Kishimoto
006
  Stress overcoming specifications of gifted children
Madlena Arakelyan, Armenia
OS-20 
Oral Presentation Session
17:00 – 18:30
 | 
Room R13
TOPIC 16:
 Diagnostics and classification, 
psychopathology, RDoC
Diagnostic and classification
Chairs: 
Jürgen Zielasek, Germany 
Michel Botbol, France
001
  Opportunities and challenges for a person-
alised approach to diagnosis and treatment
Bernhard Baune, Australia
002
  Companion diagnostic (CDx) for personalizing 
psychiatric medications
Anil Modak, USA
003
  Reshaping the diagnostic borders – the in-
troduction of the concept of schizophrenia at the 
Psychiatric Clinic of the University of Strasbourg 
(1922 – 1932)
Julie Clauss, France
Anne Danion-Grilliat, Christian Bonah, Pierre Vidailhet, 
Volker Hess
004
  Is unspecified psychosis a stable diagnosis?
Halil Ibrahim Tas, Turkey
Merve Celik, Kursat Altinbas
005
  The SCQ-AID: Social Communication Question-
naire for Adults with Intellectual Disability
Tanja Sappok, Germany
Olivia Derks, Manuel Heinrich, Whitney Brooks, Paula 
Sterkenburg, Jane McCarthy, Lisa Underwood
FS-06 
Further Session
19:15 – 21:15
 | 
Hall A8
 
 
DGPPN Mitgliederversammlung
Chair: 
Arno Deister, Germany
Early Career Psychiatrists Programme
Discover the sessions specially tailored for students and young professionals.  
Find out more on page  66.

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
125
› Tuesday, 10 October 2017
ST-10 (d) 
State-of-the-Art-Symposium
08:15 – 09:45
 | 
Hall A2
 
TOPIC 10:
 Gerontopsychiatry
 
Gerontopsychiatrie: Depression und Delir
Chairs: 
Vjera Holthoff-Detto, Germany 
Michael Hüll, Germany
001
  Komplexe Behandlungsstrategien der Altersde-
pression
Vjera Holthoff-Detto, Germany
002
  Delire bei älteren Menschen: vermeiden, erken-
nen, behandeln
Michael Hüll, Germany
S-119 Symposium
08:15 – 09:45
 | 
Hall A3
 
TOPIC 4:
 Affective disorders
Beyond classical antidepressants: experimental 
psychopharmacological interventions to treat social 
and affective disorders
Chairs: 
Malek Bajbouj, Germany 
Erich Seifritz, Switzerland
001
  Psilocybin in the treatment of affective disorders
Franz Vollenweider, Switzerland
002
  Ketamin in the treatment of affective disorders
Simone Grimm, Germany
003
  Augmentation of psychotherapy with DMT, 
ayahuasca, psilocybin and ketamin
Milan Scheidegger, Switzerland
004
  Oxytocin in the treatment of disturbed social 
interaction
Markus Heinrichs, Germany
S-120 Symposium
08:15 – 09:45
 | 
Hall A5
 
TOPIC 14:
 Neurobiology and genetics
The search for functional targets in the post-genom-
ics era of schizophrenia
Chairs: 
Dan Rujescu, Germany 
Andreas Meyer-Lindenberg, Germany
001
  Genomics of schizophrenia: where do we stand?
Dan Rujescu, Germany
002
  Translational imaging evidence for function-
ality and mechanisms of GWA-identified genetic 
variants
Andreas Meyer-Lindenberg, Germany
003
  Epigenetic processes in neuropsychiatry disorders
Moshe Szyf, Canada
S-121 Symposium
08:15 – 09:45
 | 
Hall A1
 
TOPIC 3:
 Psychotic disorders
Symptom dimensions in schizophrenia – brain  
correlates and personalised treatment options
Chairs: 
Tilo Kircher, Germany 
Werner Strik, Switzerland
001
  A three dimensional symptom structure of 
schizophrenia is linked to specific structural and 
functional brain changes
Werner Strik, Switzerland
002
  The neurobiology of formal thought disorder: 
specific for schizophrenia?
Tilo Kircher, Germany
003
  Speech graphs and brain graphs: can we 
improve outcomes of schizophrenia by targeting 
language?
Lena K. Palaniyappan, United Kingdom
004
  Language pathways in the brain and their basis